A gene therapy approach for the treatment of amyotrophic lateral sclerosis and Parkinson's disease.
Zurn
A D
AD
Gene Therapy Center, Lausanne University Medical School, Switzerland.
Tseng
J L
JL
Déglon
N
N
Joseph
J M
JM
Aebischer
P
P
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy*; D000818:Animals; D002460:Cell Line; D020934:Ciliary Neurotrophic Factor; D006224:Cricetinae; D004195:Disease Models, Animal; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D009414:Nerve Growth Factors / Q000096:biosynthesis*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis / Q000235:genetics; D010300:Parkinson Disease / Q000628:therapy*; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D014162:Transfection
D020934:Ciliary Neurotrophic Factor; C495039:GDNF protein, human; C495041:Gdnf protein, rat; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D011993:Recombinant Fusion Proteins